Keywords
Hypertension
Polypharmacy
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To address the risks associated with the practice of polypharmacy in hypertensive elderly people. Methods: This is a bibliographical, exploratory and quantitative research, based on an integrative review, in the databases Scientific Electronic Library Online (SciELO), National Library of Medicine (PubMed) and Latin American and Caribbean Literature in Health Sciences (LILACS), in addition to the Brazilian Hypertension Directive. Results: The studies resulted in categories of factors of occurrence of polypharmacy in hypertensive elderly people, sociodemographic aspects related to hypertension and the class of drugs most used by hypertensive elderly people, showing that adverse reactions, iatrogenesis, inappropriate use of medicines, drug interactions, less adherence and self-medication are risks of polypharmacy in hypertensive elderly people. Final considerations: The study points out that there is a strong relationship between aging and the emergence of chronic diseases, with Hypertension and polypharmacy being more prevalent. Therefore, it is suggested to adopt measures through the multidisciplinary team constituted by the pharmaceutical professional aiming at the quality of life of the elderly.